Likewise, pancreatic cancer progression and metastasis are promoted by ANXA1 via micro vessel development, cytoskeletal remodeling leading to cell motility, and as an agonist of formyl peptide receptors [100]. The gene discussed is ANXA1; the disease is familial pancreatic carcinoma.